MedCity News November 30, 2022
Some industry experts seem skeptical of the rumored deal between Amwell and Talkspace, while others disagree. The rumored purchasing price is $200 million at about $1.50 per share.
Amid rumors that telemedicine company Amwell is exploring purchasing online therapy company Talkspace, industry experts seem somewhat torn on if the potential deal makes sense.
What has been reported is that Amwell would acquire Talkspace for about $200 million at about $1.50 per share. It represents a steep drop from when the teletherapy company went public last year through a blank check deal with Hudson Executive Investment that valued Talkspace at $1.4 billion.
Amwell approached Talkspace in the past about an acquisition, though Talkspace turned it down, Seeking Alpha reported earlier this...